MGNX
MacroGenics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$251.71M
P/E Ratio
—
EPS
$-1.11
Beta
1.20
52W High
$4.64
52W Low
$1.19
50-Day MA
$3.65
200-Day MA
$2.29
Dividend Yield
—
Profit Margin
-44.80%
Forward P/E
60.98
PEG Ratio
0.01
About MacroGenics Inc
MacroGenics, Inc., a biopharmaceutical company, discovers and develops antibody-based therapies to treat cancer in the United States. The company is headquartered in Rockville, Maryland.
Fundamentals
| Revenue (TTM) | $157.08M |
| Gross Profit (TTM) | $-25.50M |
| EBITDA | $-56.57M |
| Operating Margin | -161.00% |
| Return on Equity | -140.30% |
| Return on Assets | -18.00% |
| Revenue/Share (TTM) | $2.48 |
| Book Value | $0.33 |
| Price-to-Book | 11.84 |
| Price-to-Sales (TTM) | 1.60 |
| EV/Revenue | 0.849 |
| EV/EBITDA | -1.54 |
| Quarterly Earnings Growth (YoY) | -70.40% |
| Quarterly Revenue Growth (YoY) | 57.50% |
| Shares Outstanding | $63.56M |
| Float | $52.44M |
| % Insiders | 3.43% |
| % Institutions | 70.82% |
Historical Volatility
HV 10-Day
53.76%
HV 20-Day
54.42%
HV 30-Day
89.06%
HV 60-Day
81.62%
HV Rank
57.1%
Volatility is currently contracting
Analyst Ratings
Consensus ($6.75 target)
1
Strong Buy2
Buy4
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026